LEO Pharma U.S. Welcomes Judit H. Nyirady as Vice President of Medical Strategy & Scientific Affairs

Thursday, May 04, 2017 | Personnel/Company News , Atopic Dermatitis , Psoriasis , Atopic Dermatitis , Eczema , Leo

Judit H. Nyirady, MD, MBA, is the new Vice President of Medical Strategy & Scientific Affairs at LEO Pharma Inc.

In this role, she will be responsible for the medical and scientific affairs strategies for LEO Pharma in the United States, as well as the U.S. Quality, Pharmacovigilance, Drug Safety, and Medical Information functions. Dr. Nyirady is a board certified dermatologist with more than 18 years of pharmaceutical experience in all aspects of clinical research and development.  She also has medical affairs expertise within both systemic and topical drugs.

Prior to joining LEO, Dr. Nyirady worked at Novartis, most recently as interim Medical Unit Head of Dermatology & Immunology, U.S. Clinical Development & Medical Affairs and concurrently as the Executive Director, Dermatology, U.S. Clinical Development & Medical Affairs.  Before joining Novartis in 2003, Dr. Nyirady worked at Johnson & Johnson Consumer Products Worldwide (CPWW) as Director of Medical Affairs, Dermatology.

She holds a M.B.A. from Cornell University, Johnson Graduate School of Management and obtained her medical degree in Hungary from Albert Szent-Györgyi Medical University.

CAPTION: Judit H. Nyirady, M.D., M.B.A. - VP, Medical Strategy & Scientific Affairs


Next Story


You must be logged in to leave a comment.